Telehealth on the rise, page-2145

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 2145 Last

Share
Profile

Follow
MSIMaker

3,769 Posts.

1149

09/04/20

08:54

Post #: 43963750
Share

Originally posted by TheSanDiegoKid ↑

BBC reporting on the cough analysis apps being developed to identify Covid-19 in the UK and how this could assist the NHS. Now whether or not Resapp is tied to either of these, it'd be nice amid all that is currently going on to get get that sort of coverage that directly references Resapp. Why wouldn't the company want to get there name out there as certified triage tech at the moment? Awareness will only drive demand from the public and speed up the rollout/sign up process. From a PR point of view it'd be any easy to sell to any of the major media outlets and yet all is reasonably quiet except a couple of very brief spots in Aus news reports and the odd article after a positive or negative announcement.

A wee thought I had today while pondering this is that maybe the company as it sits today don't plan on turning Resapp into a household name and the end goal here is a takeover by a larger company who will incorporate the tech under their own brand. Having a recognised name will only mean any potential buyer of the company will have to work harder to rebrand and gain public trust.

This scenario is only relevant if the company plans to sell in the near future. I believe that had we received FDA we would have been a very desirable takeover prospect but the setback has delayed us by another 6 - 12 months. Anyway, now I'm rambling!

The main point being, why isn't the company putting its name forward for media more than ever at this moment? I know they are busy with signing up providers etc but it doesn't take much to get a PR company to run a short term campaign for you, especially while the industry we operate in is the talk of the globe!

Expand

I have confirmed with TK that this is NOT Resapp technology in use at all.

RAP Price at posting: 18.0¢ Sentiment: Buy Disclosure: Held
18 Upvote

0 Great analysis

Reply

Top Stories

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

There are more pages in this discussion • 930 more messages in this thread...

First 2145 Last

Add RAP (ASX) to my watchlist

Telehealth on the rise, page-2145

Top Stories

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

Featured News